Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: A study of the Hoosier Oncology Group
Sayar, Hamid, Chan, Rebecca J, Orschell, Christie M, Chan, Edward M, Yu, Zhangsheng, Hood, Daniel, Plett, Artur, Yang, Zhenyun, Hui, Chua Lin, Nabinger, Sarah C, Kohlbacher, Kristopher J, West, Evan S, Walter, Amanda, Sampson, Carol, Wu, Jingwei, Cripe, Larry D
Published in Leukemia research (01.08.2011)
Published in Leukemia research (01.08.2011)
Get full text
Journal Article